Healthcare SPAC Healthwell Acquisition Aims To Raise US$250 Million In IPO

Special purpose acquisition company Healthwell Acquisition Corp. I (NASDAQ: HWELU) went public on the Nasdaq Capital Market yesterday. The firm is looking to raise US$250.0 million through its initial public offering, expected to close on August 5, 2021.

The offering consists of 25.0 million units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one-half of a purchase warrant. Each whole warrant is redeemable for one common share at US$11.50 per share.

The company units trade on the Nasdaq big board under the symbol “HWELU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “HWEL” and “HWELW”, respectively.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The proposed offering is being managed by Jefferies as the sole underwriter, which the company granted a 45-day over-allotment option to purchase additional 3.75 million company units.

The newly-organized blank check company also relayed that it will be looking to transact with firms valued between US$500 million and US$1 billion and focused on tech-enabled healthcare business.

Healthwell Acquisition last traded at US$9.90 on the Nasdaq.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Could Fall Further. Here’s What I’m Buying | Rick Rule

Newmont Crushed Q3. So Why Did the Stock Fall?

Governments Bet on Critical Minerals While Investors Panic | John Passalacqua – First Phosphate

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Tiger Williams-Led SPAC Williams Rowland Acquisition Seeks To Raise US$200 Million In IPO

Special purpose acquisition company Williams Rowland Acquisition Corp. (NYSE: WRACU) went public on the New...

Tuesday, July 27, 2021, 12:21:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under...

Thursday, July 22, 2021, 12:43:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

SPAC Blockchain Moon Acquisition Prices US$100 Million IPO

Special purpose acquisition company Blockchain Moon Acquisition Corp. (Nasdaq: BMAQU) started trading publicly on the...

Tuesday, October 19, 2021, 02:44:00 PM